Sight Sciences, Inc., was incorporated in Delaware on February 10, 2010. The Company is an ophthalmic medical device company focused on the development and commercialization of surgical and non-surgical technologies for the treatment of common eye diseases. The company's business philosophy is based on the following principles: a comprehensive understanding of disease physiology; the development of transformative technologies designed to protect, protect and restore the natural physiological functions of diseased eyes; the development and marketing of products with proven clinical evidence, These products achieve effectiveness over current treatment models while minimizing complications or side effects; provide intuitive, patient-friendly intervention solutions for ophthalmologists and optometrists; and provide compelling economic value to all stakeholders, including patients, providers and third-party payers such as health insurance companies and commercial insurance companies.